Birchview Capital, LP - Dec 5, 2021 Form 3 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role: 10%+ Owner
Signature: Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP
Stock symbol: ELUT
Transactions as of: Dec 5, 2021
Transactions value $: $0
Form type: 3
Date filed: 2/13/2023, 05:54 PM
Next filing: Feb 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ELUT	Class A Common Stock						1.42M	Dec 5, 2021	See footnotes	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of Birchview Fund, LLC.
F2	Birchview Fund, LLC acquired 1,134,905 of the shares. Matthew Strobeck personally acquired 165,094 of the shares and acquired an additional 117,924 of the shares in custodial accounts in his name (the "Strobeck Shares").
F3	Of the Strobeck Shares, all 283,018 of the Strobeck Shares were held in separately managed accounts ("SMA") for which Birchview Capital, LP provided investment advice.
F4	As the investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of all the 1,134,905 shares held by the Fund.